Altered brain white matter integrity in healthy carriers of the APOE ε4 allele

Background: Previous research has shown that polymorphisms of apolipoprotein E (APOE) represent genetic risk factors for dementia and for cognitive impairment in the elderly. The neural mechanisms by which these genetic variations influence behavioral performance or clinical severity are not well understood. Methods: The authors used diffusion tensor imaging to investigate ultrastructural properties in brain white matter to detect pathologic processes that modify tissue integrity. Sixty participants were included in the study of which 30 were homozygous for the APOE ε3 allele, 10 were homozygous for the APOE ε4 allele, and 20 had the APOE ε34 allele combination. All individuals were non-demented, and the groups were matched on demographic variables and cognitive performance. Results: The results showed a decline in fractional anisotropy, a marker for white matter integrity, in the posterior corpus callosum of ε4 carriers compared to non-carriers. Additional sites of altered white matter integrity included the medial temporal lobe. Conclusions: Although the mechanism underlying vulnerability of white matter tracts in APOE ε4 carriers is still unknown, these findings suggest that increased genetic risk for developing Alzheimer disease is associated with changes in microscopic white matter integrity well before the onset of dementia.

[1]  G. Bartzokis,et al.  Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical “disconnection” in aging and Alzheimer’s disease , 2004, Neurobiology of Aging.

[2]  L. Nyberg,et al.  Betula: A Prospective Cohort Study on Memory, Health and Aging , 2004 .

[3]  P. Basser,et al.  Water Diffusion Changes in Wallerian Degeneration and Their Dependence on White Matter Architecture , 2000 .

[4]  B. C. Richardson,et al.  Human corpus callosum in aging and alzheimer's disease: a magnetic resonance imaging study , 1994, Neurobiology of Aging.

[5]  S. Rose,et al.  Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.

[6]  D. Head,et al.  Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. , 2004, Cerebral cortex.

[7]  P. Scheltens,et al.  White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging , 1999, Journal of neurology, neurosurgery, and psychiatry.

[8]  Hirofumi Sakurai,et al.  Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer’s disease , 1999, Journal of the Neurological Sciences.

[9]  Ruth A. Carper,et al.  Atrophy of the Corpus Callosum in Alzheimer's Disease Versus Healthy Aging , 1996, Journal of the American Geriatrics Society.

[10]  G. Alexander,et al.  Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer’s disease in relation to dementia severity: evidence for early neocortical degeneration , 2003, Neurobiology of Aging.

[11]  R. Woods,et al.  Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. , 2001, Cerebral cortex.

[12]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.

[13]  Christian Beaulieu,et al.  Diffusion anisotropy in subcortical white matter and cortical gray matter: Changes with aging and the role of CSF‐suppression , 2004, Journal of magnetic resonance imaging : JMRI.

[14]  A Brun,et al.  White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. , 1988, Brain : a journal of neurology.

[15]  Jan Cees de Groot,et al.  Interaction Between Hypertension, apoE, and Cerebral White Matter Lesions , 2004, Stroke.

[16]  H. Soininen,et al.  Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes , 1995, Neuroscience.

[17]  M. Raichle,et al.  Tracking neuronal fiber pathways in the living human brain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B L Miller,et al.  Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. , 1998, Stroke.

[19]  Lars-Olof Wahlund,et al.  Postmortem MRI and Histopathology of White Matter Changes in Alzheimer Brains , 2002, Dementia and Geriatric Cognitive Disorders.

[20]  C. Newton,et al.  Analysis of apolipoprotein E genotypes by the Amplification Refractory Mutation System. , 1991, Clinical chemistry.

[21]  K. Meguro,et al.  Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[22]  John S. Duncan,et al.  Noninvasive in vivo demonstration of the connections of the human parahippocampal gyrus , 2004, NeuroImage.

[23]  K. Lim,et al.  Age‐related decline in brain white matter anisotropy measured with spatially corrected echo‐planar diffusion tensor imaging , 2000, Magnetic resonance in medicine.

[24]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[25]  P Pietrini,et al.  Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease. , 1999, Archives of neurology.

[26]  Xianlin Han,et al.  Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis , 2002, Journal of neurochemistry.